About Spore Biotechnologies
Spore Biotechnologies is a company based in Paris (France) founded in 2022 by Amine Raji and Maxime Mistretta. Spore Biotechnologies has raised $31.61 million across 3 funding rounds from investors including STATION F, Singular and Point72 Ventures. Spore Biotechnologies offers products and services including AI Microbiology Technology. Spore Biotechnologies operates in a competitive market with competitors including AFYREN, Biopsin, Mesosil, Celsis and Source Molecular, among others.
- Headquarter Paris, France
- Founders Amine Raji, Maxime Mistretta
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31.61 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
STATION F
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spore Biotechnologies
Spore Biotechnologies offers a comprehensive portfolio of products and services, including AI Microbiology Technology.
AI tool for rapid microbiology analysis and diagnostics
People of Spore Biotechnologies
Unlock access to complete
Funding Insights of Spore Biotechnologies
Spore Biotechnologies has successfully raised a total of $31.61M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spore Biotechnologies
Spore Biotechnologies has secured backing from 13 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include STATION F, Singular and Point72 Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are made in European startups.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on seed to growth stage fintech, deep tech, and enterprise tech companies
|
Locked | Locked | Locked | |
|
Startups are accelerated and incubated via structured programs.
|
Locked | Locked | Locked |
Investor details for Spore Biotechnologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spore Biotechnologies
Investment portfolio details for Spore Biotechnologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spore Biotechnologies
Detailed financials for Spore Biotechnologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spore Biotechnologies Comparisons
Peer comparison for Spore Biotechnologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spore Biotechnologies
Spore Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AFYREN, Biopsin, Mesosil, Celsis and Source Molecular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| Locked | Locked | Locked |
Real-time microbial detection system is developed for product testing.
|
|
| Locked | Locked | Locked |
Antimicrobial materials are developed for infection prevention in medical devices.
|
|
| Locked | Locked | Locked |
Rapid microbial screening systems are manufactured for quality control testing.
|
|
| Locked | Locked | Locked |
Technology for microbial source tracking is provided by Source Molecular.
|
Detailed competitors of Spore Biotechnologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spore Biotechnologies
Complete news archive for Spore Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spore Biotechnologies
Spore Biotechnologies was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Spore Biotechnologies is headquartered in Paris, France.
Amine Raji is the current CEO of Spore Biotechnologies. They have also founded this company.
Spore Biotechnologies is a funded company, having raised a total of $31.61M across 3 funding rounds to date.
Spore Biotechnologies was founded in 2022 and is based in Paris, France. Bacterial and microbial risks are detected through technologies tailored for food and beverage, cosmetics, and pharmaceuticals sectors within life sciences. Operations center on creating detection solutions to support manufacturers in risk assessment and compliance. The company is led by co-founders Amine Raji as CEO and Maxime Mistretta.
Spore Biotechnologies offers AI Microbiology Technology.
Spore Biotechnologies has 13 investors. Key investors include STATION F, Singular, Point72 Ventures, No Label Ventures, and Famille C Participations.